Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Revista colombiana de Gastroenterología
versión impresa ISSN 0120-9957versión On-line ISSN 2500-7440
Resumen
QUIGLEY, Eamonn MM; CRAIG, Orla F y DINAN, Timothy G. The role of antidepressants in the management of irritable bowel syndrome (IBS). Rev Col Gastroenterol [online]. 2011, vol.26, n.2, pp.140-146. ISSN 0120-9957.
Irritable Bowel Syndrome (IBS) is a complex entity whose etiology is unknown and whose physiopathology is incompletely known. It occurs frequently, and many treatments for it have been described. The relation of psycho-social factors to the genesis and presentation of IBS has been studied with special attention. The approach to treating IBS patients requires contemplation of the patients symptoms and reactions to his or her illness and environment. Of the multiple treatments for IBS which have been described, antidepressants have received considerable attention although their clinical utility is still not clear. The objective of this work is to review the literature regarding the physiopathological basis of IBS, comorbidities with psychiatric disorders, and the clinical usefulness of antidepressants for treating irritable bowel syndrome.
Palabras clave : Irritable bowel syndrome (IBS); antidepressants; treatment.